Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.168,37
-0,90%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Achieve Life Sciences Inc (ACHV) Achieve Life Sciences Inc (ACHV) Notizie

Achieve Life Sciences Inc

ACHV
4,70
0,125 (2,73%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202414:00GLOBEAchieve Life Sciences to Announce First Quarter Financial..
11/4/202414:00GLOBEAchieve Life Sciences to Present at Life Science Innovation..
28/3/202421:01GLOBEAchieve Life Sciences Reports Financial Results for Fourth..
20/3/202413:00GLOBEAchieve Life Sciences Announces Data from Cytisinicline ORCA..
14/3/202413:00GLOBEAchieve Life Sciences to Announce Fourth Quarter and..
06/3/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:41EDGAR2Form 8-K - Current report
29/2/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202414:01GLOBEAchieve Life Sciences Reaches Agreement with the FDA on..
29/2/202414:00GLOBEAchieve Life Sciences Announces Pricing of up to $124.2..
27/2/202421:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/1/202420:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202322:04EDGAR2Form 8-K - Current report
09/11/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:00GLOBEAchieve Life Sciences Reports Financial Results for Third..
26/10/202314:00GLOBEAchieve Life Sciences to Announce Third Quarter 2023..
03/10/202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
11/9/202314:00GLOBEAchieve Life Sciences Announces Presentation of..
07/9/202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
14/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:06EDGAR2Form 8-K - Current report
14/8/202322:00GLOBEAchieve Life Sciences Reports Financial Results for Second..
01/8/202314:00GLOBEAchieve Life Sciences to Announce Second Quarter 2023..
18/7/202314:00GLOBEAchieve Life Sciences Announces Presentation at 2023..
11/7/202317:23GLOBEAchieve Life Sciences Announces Publication of Cytisinicline..
06/6/202314:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
25/5/202315:00GLOBEAchieve Life Sciences Announces Pricing of $16.5 Million..
23/5/202312:00GLOBEAchieve Life Sciences Reports Statistically Significant..
17/5/202314:00GLOBEAchieve Life Sciences Announces Refinancing of Outstanding..
09/5/202322:05GLOBEAchieve Life Sciences Reports Financial Results for First..
Apertura: 4,57 Min: 4,48 Max: 4,64
Chiusura: 4,575

La tua Cronologia

NASDAQ
ACHV
Achieve Life Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network